Background and Objectives: Positive impacts of sugar-free chewing-gum (SFCG) were largely described in the literature. In addition to the increase in salivary flow and the mechanic effect of CG, their main ingredient, i.e., polyols, can also have some specific benefits on oral health on their own. Some have been shown to have a bacteriostatic effect on acid-producing bacteria, and others have been shown to be particularly active on dental plaque early colonizers, resulting in both a reduction in dental caries prevalence or a decrease in gums inflammation. Here, we aimed to demonstrate these positive effects using the tablet vector only composed of compressed polyols. Methods: We used a customized inversed pH-telemetry test that is often used to demonstrate the "safe for teeth" characteristics of a food product. This inversed pH-telemetry test was designed to evaluate the potential of a food product to counteract the dental plaque drop in pH following a sucrose challenge, according to the regulatory advised test. It was performed on five healthy volunteers that grew 5-day dental plaque over a micro electrode to measure their pH in situ. Three different tablets were tested: 100% maltitol versus 100% sorbitol versus control tablets (70% starch + 30% resistant dextrin). Results: For each tablet, a neutralization score was calculated as the difference in the pH values (pH values at the end of the consumption of the respective tablets—pH value just before consumption of the tablets). Positive values indicate a neutralization (increase in pH during the consumption of the product), meaning that the neutralization with maltitol tablets was the greatest among tested tablets (p = 0.003 vs. control). Sorbitol tablets also had a significant impact (p = 0.01 vs. control). Discussion/Conclusions: This inversed pH-telemetry was designed to show a neutralizing effect of polyol tablets as it has been conducted with sugar-free chewing-gums. We demonstrated here that tablets were also able to counteract the dental plaque pH drop induced by a sucrose challenge, showing clearly that tablets should also be considered as oral health beneficial products. Consequently, the consumption of polyols in various vectors should be regulatory, as is recommended for SFCG.
No takes yet. Share an insight, caveat, or question.
Perreau et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: